AusperBio Reports Phase 2 Clinical Data for Hepatitis B Oligonucleotide Therapy
May 27, 2026 15:47
CST Updated
18:07
AusperBio
Biological Vaccine and Nucleic Acid Drug Developer
Biological Vaccine and Nucleic Acid Drug Developer